secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001641172-25-017165
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics closes $5M public offering, net proceeds ~$4.3M
--------------------------------------------------------------

- Gross proceeds $5M from 1.25M shares (or pre-funded) plus Series D/E warrants; net ~$4.3M after fees.
- Series D warrants (5-year, $4 strike) and Series E warrants (18-month, $4 strike); potential $10M if fully exercised.
- Proceeds to fund clinical trials, patent portfolio, and working capital.
- H.C. Wainwright acted as exclusive placement agent; fees 7% of gross plus 1% management fee.
- After closing, approximately 1.6M shares of common stock outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000164117225017165/0001641172-25-017165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000164117225017165/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer